Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | ARCUS BIOSCIENCES INC RCUS | PFM Health Sciences LP | 2,703,287 3.700% | -1,229,946 (-31.27%) | Filing History |
| 2023-02-14 11:58 am Sale | 2022-12-31 | 13G | ARCUS BIOSCIENCES INC RCUS | BIOTECHNOLOGY VALUE FUND L P | 2,303,520 3.200% | -1,657,428 (-41.84%) | Filing History |
| 2023-02-09 5:42 pm Sale | 2022-12-31 | 13G | ARCUS BIOSCIENCES INC RCUS | EcoR1 Capital, LLC | 0 0.000% | -5,523,358 (Position Closed) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | ARCUS BIOSCIENCES INC RCUS | VANGUARD GROUP INC | 4,373,177 6.040% | 4,373,177 (New Position) | Filing History |
| 2023-01-26 08:43 am Unchanged | 2022-12-31 | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 9,389,048 13.000% | 0 (Unchanged) | Filing History |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 9,389,048 13.000% | 1,421,371 (+17.84%) | Filing History |
| 2022-10-17 4:01 pm Purchase | 2022-10-06 | 13G | ARCUS BIOSCIENCES INC RCUS | PFM Health Sciences LP | 3,933,233 5.500% | 502,223 (+14.64%) | Filing History |
| 2022-05-09 3:23 pm Purchase | 2022-04-30 | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 7,967,677 11.100% | 3,837,748 (+92.93%) | Filing History |
| 2022-03-14 4:48 pm Purchase | 2022-03-03 | 13G | ARCUS BIOSCIENCES INC RCUS | BIOTECHNOLOGY VALUE FUND L P | 3,960,948 5.600% | 1,208,726 (+43.92%) | Filing History |
| 2022-02-14 4:02 pm Purchase | 2021-12-31 | 13G | ARCUS BIOSCIENCES INC RCUS | EcoR1 Capital, LLC | 5,523,358 7.900% | 951,311 (+20.81%) | Filing History |
| 2022-02-14 12:38 pm Purchase | 2021-12-31 | 13G | ARCUS BIOSCIENCES INC RCUS | PFM Health Sciences LP | 3,431,010 4.900% | 57,550 (+1.71%) | Filing History |
| 2022-02-14 12:30 pm Sale | 2021-12-31 | 13G | ARCUS BIOSCIENCES INC RCUS | GV 2016, L.P. | 2,563,441 3.650% | -2,486,345 (-49.24%) | Filing History |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | ARCUS BIOSCIENCES INC RCUS | BlackRock Inc. BLK | 4,129,929 5.900% | 758,628 (+22.50%) | Filing History |
| 2021-07-19 5:16 pm Purchase | 2021-07-09 | 13G | ARCUS BIOSCIENCES INC RCUS | EcoR1 Capital, LLC | 4,572,047 6.400% | 4,572,047 (New Position) | Filing History |